Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science

Journal of Law, Medicine and Ethics 37 (4):685-687 (2009)
  Copy   BIBTEX

Abstract

This commentary asks what we can learn from our oversight of controversial science and how can we do better in the future? After briefly examining the history of gene transfer research oversight, some observations are offered for the oversight of nanobiotechnology and other emerging areas of science

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.2009.00440.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 93,774

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
Developing U.S. Oversight Strategies for Nanobiotechnology: Learning from Past Oversight Experiences.Jordan Paradise, Susan M. Wolf, Jennifer Kuzma, Aliya Kuzhabekova, Alison W. Tisdale, Efrosini Kokkoli & Gurumurthy Ramachandran - 2009 - Journal of Law, Medicine and Ethics 37 (4):688-705.
RAC Oversight of Gene Transfer Research: A Model Worth Extending?Nancy M. P. King - 2002 - Journal of Law, Medicine and Ethics 30 (3):381-389.
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.Robbin Johnson - 2009 - Journal of Law, Medicine and Ethics 37 (4):587-593.
Evaluating Oversight of Human Drugs and Medical Devices: A Case Study of the FDA and Implications for Nanobiotechnology.Jordan Paradise, Alison W. Tisdale, Ralph F. Hall & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):598-624.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
What Does the History of Technology Regulation Teach Us about Nano Oversight?Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott - 2009 - Journal of Law, Medicine and Ethics 37 (4):724-731.
The Challenge of Developing Oversight Approaches to Nanobiotechnology.Jordan Paradise, Susan M. Wolf, Jennifer Kuzma, Gurumurthy Ramachandran & Efrosini Kokkoli - 2009 - Journal of Law, Medicine and Ethics 37 (4):543-545.
Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.Robbin Johnson - 2009 - Journal of Law, Medicine and Ethics 37 (4):587-593.

Analytics

Added to PP
2010-09-13

Downloads
12 (#317,170)

6 months
7 (#1,397,300)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.

Add more references